The U.S. government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers' testing and manufacturing, the companies said on Friday.
) when it inked a nearly $2 billion deal for 50 million courses of that potential vaccine last week.
Sanofi executive Clement Lewin said the companies had not yet agreed with the government on a specific price for the additional doses. The two companies’ inoculation is combination of a vaccine based on Sanofi’s flu shots and a complementary technology from GSK called an adjuvant, designed to improve the vaccine’s potency.It marks the second contract for the Franco-British pair’s vaccine candidate after they agreed earlier this week to supply 60 million doses to the British government.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
TikTok to give creators over $2 billion in the next 3 years as it takes on Instagram and YouTube“Access to direct monetization pathways keeps top creatives posting on TikTok, and may also attract creators from competitors,” said one analyst.
Weiterlesen »
'Vaccine nationalism': Is it every country for itself?A slew of bilateral deals between governments and drugmakers to secure millions of doses of COVID-19 vaccines is putting at risk a WHO co-led initiative to bulk-buy and equitably distribute the pandemic vaccines around the world
Weiterlesen »
U.S. government to launch 'overwhelming' COVID-19 vaccine campaign by NovemberThe Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration official said.
Weiterlesen »
Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)Two new studies involving monkeys suggest COVID-19 vaccine candidates can provide disease protection after a single injection — but it will take large-scale human trials to know for sure if they work.
Weiterlesen »
Exclusive: Chinese-backed hackers targeted COVID-19 vaccine firm ModernaChinese government-linked hackers targeted biotech company Moderna Inc , a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a U.S. security official tracking Chinese hacking activity.
Weiterlesen »